** Shares of Proteomics International Laboratories surge as much as 24% to A$0.750, their biggest one-day pct gain since Oct. 8
** Medical technology firm reports that its PromarkerEndo plasma protein biomarker panel accurately identifies all stages of endometriosis
** Endometriosis is a condition causing uterine-like tissue growth outside the uterus, affecting roughly 10% of reproductive age women and girls according to the WHO
** The condition takes an average of seven years to diagnose
** PIQ sets sights on Q2 CY25 for Australian launch of its product
** Stock hits its highest level since Oct. 29
** Including session's moves, stock trims YTD losses to 19% as of 0050 GMT
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。